---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-041285"
form_type: "8-K/A"
ticker: "SIGY"
cik: "0001642159"
company_name: "Sigyn Therapeutics, Inc."
filed_at: "2024-10-16T23:59:59+00:00"
generated_at: "2026-05-30T13:44:40.467086+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# Sigyn corrects prior error; debenture conversion adds 118,700 shares, 9.1% share increase

## Summary
- Corrected prior error: sellers were not controlled by an executive officer.
- $474,793 of convertible debentures converted at $4.00/share for 118,700 shares.
- Shares issued with Rule 144 legend, exempt under Section 4(a)(2).
- Outstanding common shares increased from 1,301,978 to 1,420,678.

## SEC filing metadata
- accession: 0001493152-24-041285
- form_type: 8-K/A
- ticker: SIGY
- cik: 0001642159
- company_name: Sigyn Therapeutics, Inc.
- filed_at: 2024-10-16T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 3.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1642159/000149315224041285/0001493152-24-041285-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1642159/000149315224041285/form8-ka.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-041285
- JSON: https://secwatch.observer/filing/0001493152-24-041285.json
- Plain text: https://secwatch.observer/filing/0001493152-24-041285.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.